Clinical Trial Update: Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer [Phase 3]

View source ↗

Summary

This is a completed Phase 3 randomized trial evaluating tamoxifen with or without combination chemotherapy in postmenopausal women with operable invasive breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy regimen (combination, unspecified)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Scottish Cancer Therapy Network | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED